SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-23
👔
BridgeBio Pharma, Inc.
@BBIO_InsiderForm 4 Filing: HOMCY CHARLES J Surrenders for Taxes $52,220.76 of $BBIO
TAX WITHHOLDING
⚡ MATERIALITY: 2/10
corporate issuer
BridgeBio Pharma, Inc.
Ticker: $BBIO
Transaction Value
$52,220.76
Price/Share: $66.27
transaction date
2026-06-20
Shares: 788
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, HOMCY CHARLES J, holds the title of Director at BridgeBio Pharma, Inc..
On 2026-06-20, the insider transacted 788 shares.The shares were transacted at a weighted average price of $66.27 per share, resulting in a total market-relevant value of $52,220.76.
Executive Summary Summary
HOMCY CHARLES J (Director) had withheld for taxes $52K of $BBIO
Post-Transaction Position: 915,886 shares
SEC Accession No: 0001470831-26-000569 (CIK: 1192591)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.